Dose and time dependence of box jellyfish antivenom

Athena Andreosso1, Michael J Smout2, Jamie E Seymour1

  • 1Australian Institute of Tropical Health and Medicine, Faculty of Medicine, Health and Molecular Sciences, James Cook University, McGregor Road, 4878 Cairns, Australia.

Abstract

Insights

The current box jellyfish (Chironex fleckeri) antivenom dose may be insufficient. Higher concentrations and longer incubation times significantly improve venom neutralization, suggesting a need for adjusted dosing and prompt resuscitation.

Area of Science:

  • Marine Biology
  • Toxicology
  • Pharmacology

Background:

  • The efficacy of current box jellyfish (Chironex fleckeri) antivenom is debated.
  • Cellular-level assessment of antivenom effectiveness is needed.

Purpose of the Study:

  • To evaluate the dose and time dependence of Chironex fleckeri antivenom in a cell-based assay.
  • To determine if antivenom can attenuate venom-induced cellular damage.

Main Methods:

  • Utilized xCelligence Technology (ACEA Biosciences) to measure cell index and survival.
  • Assessed antivenom effectiveness across varying doses and venom-antivenom incubation times.
  • Employed one-way ANOVA with LSD post hoc test for statistical significance.

Main Results:

  • Higher antivenom concentrations significantly increased cell survival.
  • Approximately five times the recommended human dose was needed for a significant survival increase.
  • Antivenom neutralization of venom required approximately 70 minutes of incubation.

Conclusions:

  • The current Chironex fleckeri antivenom dose requires adjustment.
  • Higher antivenom concentrations and longer pre-incubation times are more effective.
  • Immediate and prolonged cardiopulmonary resuscitation is critical due to delayed antivenom effects.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
525
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
419
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
228
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
362